Literature DB >> 1382621

Leukocytoclastic vasculitis complicating granulocyte colony-stimulating factor (G-CSF) induced neutrophil recovery in T gamma-lymphocytosis with severe neutropenia.

G Schliesser, H Pralle, J Lohmeyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1382621     DOI： 10.1007/bf01695817

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  11 in total

1.  Differential effect of G-CSF and GM-CSF in acquired chronic neutropenia.

Authors:  M A Wodzinski; K K Hampton; J T Reilly
Journal:  Br J Haematol       Date:  1991-02       Impact factor: 6.998

2.  Use of recombinant human granulocyte-macrophage colony stimulating factor in T-lymphocytosis with granulocytopenia.

Authors:  G Krieger; M Kneba; K Vehmeyer; G A Nagel; K Welte
Journal:  Eur J Haematol       Date:  1990-03       Impact factor: 2.997

3.  Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.

Authors:  W P Hammond; T H Price; L M Souza; D C Dale
Journal:  N Engl J Med       Date:  1989-05-18       Impact factor: 91.245

4.  Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.

Authors:  J A Glaspy; G C Baldwin; P A Robertson; L Souza; M Vincent; J Ambersley; D W Golde
Journal:  Ann Intern Med       Date:  1988-11-15       Impact factor: 25.391

5.  Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia.

Authors:  A A Jakubowski; L Souza; F Kelly; K Fain; D Budman; B Clarkson; M A Bonilla; M A Moore; J Gabrilove
Journal:  N Engl J Med       Date:  1989-01-05       Impact factor: 91.245

6.  Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.

Authors:  K Welte; C Zeidler; A Reiter; W Müller; E Odenwald; L Souza; H Riehm
Journal:  Blood       Date:  1990-03-01       Impact factor: 22.113

7.  Eosinophilia resulting from administration of recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in a patient with T-gamma lymphoproliferative disease.

Authors:  R Gonzales-Chambers; C Rosenfeld; A Winkelstein; L Dameshek
Journal:  Am J Hematol       Date:  1991-02       Impact factor: 10.047

8.  Childhood polyclonal T cell lymphocytosis with neutropenia: effects of antilymphocyte globulin and granulocyte colony stimulating factor in vitro and in vivo.

Authors:  A S Laurie; F M Gibson; K M Josten; P J Talbot; T R Rutherford; J S Lilleyman; E C Gordon-Smith
Journal:  Br J Haematol       Date:  1992-04       Impact factor: 6.998

9.  Proliferation of T gamma cells with killer-cell activity in two patients with neutropenia and recurrent infections.

Authors:  A A Bom-van Noorloos; H G Pegels; R H van Oers; J Silberbusch; T M Feltkamp-Vroom; R Goudsmit; W P Zeijlemaker; A E von dem Borne; C J Melief
Journal:  N Engl J Med       Date:  1980-04-24       Impact factor: 91.245

10.  Agranulocytosis associated with T-gamma-lymphocytosis: no improvement of peripheral blood granulocyte count with human-recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF).

Authors:  C Thomssen; C Nissen; A Gratwohl; A Tichelli; A Stern
Journal:  Br J Haematol       Date:  1989-01       Impact factor: 6.998
View more
  3 in total

Review 1.  Drug-induced vasculitis.

Authors:  Marta Lucia Cuellar
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 2.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

Review 3.  Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia.

Authors:  J E Frampton; C R Lee; D Faulds
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.